KR101808977B1 - 약물 전달 시스템 - Google Patents

약물 전달 시스템 Download PDF

Info

Publication number
KR101808977B1
KR101808977B1 KR1020167018119A KR20167018119A KR101808977B1 KR 101808977 B1 KR101808977 B1 KR 101808977B1 KR 1020167018119 A KR1020167018119 A KR 1020167018119A KR 20167018119 A KR20167018119 A KR 20167018119A KR 101808977 B1 KR101808977 B1 KR 101808977B1
Authority
KR
South Korea
Prior art keywords
vinyl acetate
drug delivery
delivery system
ethylene
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167018119A
Other languages
English (en)
Korean (ko)
Other versions
KR20160095110A (ko
Inventor
빌리 제이.에이치. 베르후번
바우터 드 그라프
Original Assignee
머크 샤프 앤 도메 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 머크 샤프 앤 도메 비.브이. filed Critical 머크 샤프 앤 도메 비.브이.
Publication of KR20160095110A publication Critical patent/KR20160095110A/ko
Application granted granted Critical
Publication of KR101808977B1 publication Critical patent/KR101808977B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020167018119A 2013-12-11 2014-12-08 약물 전달 시스템 Active KR101808977B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361914500P 2013-12-11 2013-12-11
EP13196737 2013-12-11
US61/914,500 2013-12-11
EP13196737.4 2013-12-12
PCT/EP2014/076823 WO2015086491A1 (en) 2013-12-11 2014-12-08 Drug delivery system.

Publications (2)

Publication Number Publication Date
KR20160095110A KR20160095110A (ko) 2016-08-10
KR101808977B1 true KR101808977B1 (ko) 2017-12-13

Family

ID=49759119

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167018119A Active KR101808977B1 (ko) 2013-12-11 2014-12-08 약물 전달 시스템

Country Status (23)

Country Link
US (1) US10413504B2 (https=)
EP (1) EP3079660B1 (https=)
JP (1) JP6251396B2 (https=)
KR (1) KR101808977B1 (https=)
CN (1) CN105979930B (https=)
AP (1) AP2016009223A0 (https=)
AU (1) AU2014363724B2 (https=)
BR (1) BR112016013325B1 (https=)
CA (1) CA2931559C (https=)
CR (1) CR20160261A (https=)
DO (1) DOP2016000132A (https=)
EA (1) EA031802B1 (https=)
HK (1) HK1224208A1 (https=)
IL (1) IL245544A0 (https=)
MA (1) MA39059A1 (https=)
MD (1) MD20160079A2 (https=)
MX (1) MX2016007681A (https=)
PE (1) PE20160680A1 (https=)
PH (1) PH12016501083A1 (https=)
SG (1) SG11201604660VA (https=)
SV (1) SV2016005214A (https=)
TW (1) TW201607563A (https=)
WO (1) WO2015086491A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
WO2015086489A1 (en) 2013-12-11 2015-06-18 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
WO2015094759A1 (en) 2013-12-19 2015-06-25 The Procter & Gamble Company Shaping keratin fibres using an active agent comprising at least two functional groups selected from: -c(oh)- and -c(=o)oh
EP3082735B1 (en) 2013-12-19 2018-05-02 The Procter and Gamble Company Shaping keratin fibres using oxoethanoic acid and/or derivatives thereof
MX361100B (es) 2013-12-19 2018-11-27 Procter & Gamble Modelado de fibras de queratina mediante el uso de un azucar.
MX376963B (es) 2013-12-19 2025-03-07 Procter & Gamble Modelado de fibras de queratina mediante el uso de éster de carbonato.
CN105828786B (zh) 2013-12-19 2020-07-07 宝洁公司 使用包含选自-c(＝o)-、-c(＝o)-h和-c(＝o)-o-的官能团的an活性剂使角蛋白纤维成形
EP3082750A1 (en) 2013-12-19 2016-10-26 The Procter & Gamble Company Shaping keratin fibres using a reducing composition and a fixing composition
MX357743B (es) 2013-12-19 2018-07-23 Procter & Gamble Formacion de fibras de queratina con 2-hidroxipropano-1,2,3-acido tricarboxilico y/o 1,2,3,4-acido butanetetracarboxilico.
EP3017809A1 (en) * 2014-11-07 2016-05-11 Ferring B.V. Drug-device unit containing quinagolide
EP3297731A1 (en) 2014-12-19 2018-03-28 The Procter and Gamble Company Shaping keratin fibres using arabinose and ethylene carbonate
EP3297730A1 (en) 2014-12-19 2018-03-28 The Procter and Gamble Company Method of shaping keratin fibres
US10945931B2 (en) 2015-06-18 2021-03-16 The Procter And Gamble Company Shaping keratin fibres using dialdehyde compounds
US20180228942A1 (en) * 2015-08-11 2018-08-16 Ptt Holding Aps A delivery device
EP3395335A1 (en) * 2017-04-24 2018-10-31 Kern Pharma, S.L. Vaginal ring for the simultaneous release of two active ingredients
DE102017113166A1 (de) * 2017-06-14 2018-12-20 Amw Gmbh Depotform zur Abgabe eines Östrogen-Wirkstoffs
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
MX2020012459A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
KR20260007295A (ko) 2018-05-24 2026-01-13 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular
EP4215180A1 (en) * 2022-01-21 2023-07-26 Sever Pharma Solutions A drug delivery system
EP4465939A4 (en) * 2022-01-21 2026-01-07 The Population Council Inc Intravaginal Combination Therapy Rings
WO2024115763A1 (en) 2022-12-02 2024-06-06 Vari Bioscience Gmbh Estriol vaginal ring

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004103336A2 (en) * 2003-05-23 2004-12-02 Akzo Nobel N.V. Drug delivery system

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3995634A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US3995633A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal Medicament dispensing device
US4237885A (en) 1978-10-23 1980-12-09 Alza Corporation Delivery system with mated members for storing and releasing a plurality of beneficial agents
US4292965A (en) 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (de) 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4629449A (en) 1982-07-29 1986-12-16 Alza Corporation Vaginal dispenser for dispensing beneficial hormone
EP0162492B1 (en) 1984-04-11 1989-08-02 Thiemann Arzneimittel GmbH Dosage units for controlled release of active material
US4596576A (en) 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
US4816258A (en) 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
EP0303306B1 (en) 1987-08-08 1993-03-10 Akzo N.V. Contraceptive implant
AU3432689A (en) 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
US5766632A (en) 1993-10-01 1998-06-16 Legere Pharmaceuticals, Ltd. Method of using lectins for contraception
JP3720386B2 (ja) 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
WO1997002015A1 (en) 1995-07-04 1997-01-23 Akzo Nobel N.V. Ring-shaped devices
US5972372A (en) 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
IL123813A0 (en) 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
ATE246638T1 (de) 1997-12-12 2003-08-15 Akzo Nobel Nv Verpackung für einen vaginalring
PL341209A1 (en) 1997-12-18 2001-03-26 Lilly Co Eli Crystalline teriparatide
US6579533B1 (en) 1999-11-30 2003-06-17 Bioasborbable Concepts, Ltd. Bioabsorbable drug delivery system for local treatment and prevention of infections
WO2002076426A2 (en) 2001-03-27 2002-10-03 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of an antimicrobial agent
WO2003000156A1 (en) 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
AU2002313517B2 (en) 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
NZ532096A (en) 2001-09-28 2006-10-27 Mcneil Ppc Inc Dosage forms having an inner core and outer shell with different shapes
CN1242819C (zh) 2002-06-07 2006-02-22 上海市计划生育科学研究所 一种新型阴道环及制备方法
US6992219B2 (en) 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
CA2531640C (en) 2003-07-10 2013-06-18 Galen (Chemicals) Limited Intravaginal drug delivery devices
PL1670440T3 (pl) * 2003-09-29 2014-11-28 Novo Nordisk Healthcare Ag Preparaty HRT
WO2005089723A1 (en) * 2004-03-24 2005-09-29 N.V. Organon Drug delivery system based on polyethylene vinylacetate copolymers
KR20060046263A (ko) * 2004-08-04 2006-05-17 도쿄파츠고교 가부시키가이샤 편평형 진동모터를 내장시킨 전자음향변환기
TW200727920A (en) 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
NZ577014A (en) 2006-11-20 2011-07-29 Organon Nv Helically-shaped drug delivery system
US10258571B2 (en) 2007-02-12 2019-04-16 Particle Sciences, Inc. Delivery devices containing encapsulated and/or practice-bound active pharmaceutical ingredients
PE20081895A1 (es) 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral
DK2207529T3 (en) 2007-09-07 2015-03-09 Mati Therapeutics Inc PHARMACEUTICAL cores for the sustained release of therapeutic agents
TW200930343A (en) 2007-09-21 2009-07-16 Organon Nv Drug delivery system
TW200927141A (en) 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
CN102497855B (zh) 2009-07-21 2013-12-25 人口委员会股份有限公司 多层梯度的阴道环
EP2468750A1 (en) 2010-12-13 2012-06-27 Chemo Ibérica, S.A. Polymorphic forms of asenapine maleate and processes for their preparation
TW201332585A (zh) 2012-02-14 2013-08-16 Chemo Res S L 核鞘藥物遞送裝置
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004103336A2 (en) * 2003-05-23 2004-12-02 Akzo Nobel N.V. Drug delivery system

Also Published As

Publication number Publication date
EP3079660B1 (en) 2021-03-03
AU2014363724A1 (en) 2016-05-26
PH12016501083A1 (en) 2016-07-25
SV2016005214A (es) 2016-11-21
CN105979930B (zh) 2019-11-19
US10413504B2 (en) 2019-09-17
HK1224208A1 (zh) 2017-08-18
PE20160680A1 (es) 2016-07-31
US20150157561A1 (en) 2015-06-11
DOP2016000132A (es) 2016-07-31
CA2931559A1 (en) 2015-06-18
JP6251396B2 (ja) 2017-12-20
BR112016013325B1 (pt) 2022-11-29
AU2014363724B2 (en) 2017-02-23
SG11201604660VA (en) 2016-07-28
MX2016007681A (es) 2016-10-14
EA201691193A1 (ru) 2016-09-30
WO2015086491A1 (en) 2015-06-18
IL245544A0 (en) 2016-06-30
EA031802B1 (ru) 2019-02-28
EP3079660A1 (en) 2016-10-19
JP2016539991A (ja) 2016-12-22
CN105979930A (zh) 2016-09-28
CR20160261A (es) 2016-08-16
BR112016013325A2 (https=) 2017-08-08
MD20160079A2 (ro) 2016-10-31
TW201607563A (zh) 2016-03-01
AP2016009223A0 (en) 2016-05-31
KR20160095110A (ko) 2016-08-10
MA39059A1 (fr) 2018-08-31
CA2931559C (en) 2018-03-13

Similar Documents

Publication Publication Date Title
KR101808977B1 (ko) 약물 전달 시스템
CA2524665C (en) Drug delivery system
CN101827569B (zh) 药物递送系统
US20100104619A1 (en) Delivery system for a non-steroidal non-ionized hydrophilic drug
KR102874143B1 (ko) 질내 링
HK1084337B (en) Drug delivery system

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

Patent event date: 20160706

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170531

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20171124

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20171207

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20171207

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20201005

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20201005

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20210929

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20210929

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20220921

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20220921

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20230921

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee